BGAM
MRK icon

Boussard & Gavaudan Asset Management’s Merck MRK Stock Holding History

Boussard & Gavaudan Asset Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-4,538
Closed -$217K – 120
2013
Q4 		$217K Buy
+4,538
New +$207K 0.15% 75

Other funds holding MRK

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Boussard & Gavaudan Asset Management's MRK Position: Q1 2014 in Review

Boussard & Gavaudan Asset Management sold out of Merck (MRK) in Q1 2014, closing a stake of 4,538 shares — an estimated $217K sold.

Boussard & Gavaudan Asset Management first reported a position in MRK in Q4 2013 and held it in 1 quarter. The position peaked at $217K in Q4 2013. 1,602 funds tracked by Wall St. Rank hold MRK as of Q1 2014.

  • Boussard & Gavaudan Asset Management reported no remaining Merck position as of Q1 2014 after selling out during the quarter.
  • Boussard & Gavaudan Asset Management sold 4,538 Merck shares in Q1 2014, an estimated $217K.
  • Boussard & Gavaudan Asset Management first reported a position in Merck in Q4 2013 and held it in 1 quarter.
  • Boussard & Gavaudan Asset Management's Merck position peaked at $217K in Q4 2013.
  • 1,602 funds tracked by Wall St. Rank held Merck as of Q1 2014.

Based on Boussard & Gavaudan Asset Management's 13F filing for Q1 2014, filed 28 Apr 2014.